TY - JOUR
T1 - Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
AU - On behalf of the GIVES-21 Consortium
AU - Mak, Joyce W.Y.
AU - Sun, Yang
AU - Limsrivilai, Julajak
AU - Abdullah, Murdani
AU - Kaibullayeva, Jamilya
AU - Balderramo, Domingo
AU - Vergara, Beatriz Iade
AU - Paudel, Mukesh Sharma
AU - Banerjee, Rupa
AU - Hilmi, Ida
AU - Ali, Raja Affendi Raja
AU - Wei, Shu Chen
AU - Ng, Ka Kei
AU - Altuwaijri, Mansour
AU - Kelly, Paul
AU - Yamamoto-Furusho, Jesus K.
AU - Kotze, Paulo Gustavo
AU - Ahuja, Vineet
AU - Chong, Vui Heng
AU - Dao, Hang Viet
AU - Abbey, Yvonne
AU - Ching, Jessica Y.L.
AU - Ho, Agnes
AU - Chan, Alicia K.W.
AU - Bernstein, Charles N.
AU - Gearry, Richard B.
AU - Abreu, Maria
AU - Rubin, David T.
AU - Dotan, Iris
AU - Hracs, Lindsay
AU - Kaplan, Gilaad G.
AU - Ng, Siew C.
AU - Tao, Yan
AU - Rong, Jiamei
AU - Chen, Xiaocui
AU - Song, Huixian
AU - Zhou, Chan
AU - Mu, Yanju
AU - Wei, Wenjuan
AU - Bai, Xinyu
AU - Aniwan, Satimai
AU - Kitiyakara, Taya
AU - Harinwan, Kamin
AU - Bunchorntavakul, Chalermrat
AU - Techathuvanan, Karjpong
AU - Kijdamrongthum, Phuripong
AU - Suttichaimongkol, Tanita
AU - Wetwittayakhlang, Panu
AU - Simadibrata, Marcellus
AU - Syam, Ari Fahrial
N1 - Funding Information:
Dr. Gearry has received honoraria, consultancy, or research grants from AbbVie, Janssen, Celltrion, Takeda, Ferring and Zespri.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. Methods: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. Results: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. Conclusions: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries.
AB - Background: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. Methods: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. Results: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. Conclusions: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries.
KW - Diet
KW - Environmental
KW - Incidence
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85160432453&partnerID=8YFLogxK
U2 - 10.1186/s12874-023-01944-2
DO - 10.1186/s12874-023-01944-2
M3 - Article
C2 - 37231405
AN - SCOPUS:85160432453
SN - 1471-2288
VL - 23
JO - BMC Medical Research Methodology
JF - BMC Medical Research Methodology
IS - 1
M1 - 129
ER -